LEGEND-T2DM Disclosures

• This protocol is undertaken within Observational Health Data Sciences and Informatics (OHDSI), an open collaboration.

• MAS receives grant funding from the US National Institutes of Health, the US Department of Veterans Affairs and the US Food & Drug Administration and contracts from Janssen Research.

• MJS and PBR are employees of Janssen Research and Development and shareholders in John & Johnson.

• GH receives grant funding from the US National Institutes of Health and the US Food & Drug Administration and contracts from Janssen Research and Development.

• HMK receives grants from the US Food & Drug Administration, Medtronics and Janssen Research and Development, is co-founder of HugoHealth and chairs the Cardiac Scientific Advisory Board for UnitedHealth.

• RK is a founder of Evidence2Health, and receives grant funding from the US National Institutes of Health, Doris Duke Charitable Foundation, and Bristol-Myers Squibb.